Succinylcholine for Emergency Airway Rescue in Class B Ambulatory Facilities: The Society for Ambulatory Anesthesia Position Statement.
expert_opinion · Level V
Where this comes from
- Record sourced from PubMed, PMID 27984222.
- Also identified by DOI 10.1213/ANE.0000000000001682.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Procedures in class B ambulatory facilities are performed exclusively with oral or IV sedative-hypnotics and/or analgesics. These facilities typically do not stock dantrolene because no known triggers of malignant hyperthermia (ie, inhaled anesthetics and succinylcholine) are available. This article argues that, in the absence of succinylcholine, the morbidity and mortality from laryngospasm can be significant, indeed, higher than the unlikely scenario of succinylcholine-triggered malignant hyperthermia. The Society for Ambulatory Anesthesia (SAMBA) position statement for the use of succinylcholine for emergency airway management is presented.
Medical subject headings
- Airway Management
- Ambulatory Care
- Anesthesia
- Laryngismus
- Malignant Hyperthermia
- Neuromuscular Depolarizing Agents
- Succinylcholine